相关实验视频

Updated: Jun 7, 2025

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors

Published on: September 27, 2019

合成大麻素激动剂WIN 55,212-2通过CB2受体激活来减少实验性

Antonio Matt Reck¹, David P Siderovski², Steven G Kinsey³

¹School of Nursing, University of Connecticut, Storrs, CT, USA; Department of Psychological Sciences, University of Connecticut, Storrs, CT, USA.

Neuropharmacology

|November 17, 2024

概括

大麻素,特别是针对CB2受体,显示减少的承诺,而不会引起镇静. 然而,大麻成分β-caryophyllene可能会使恶化.

科学领域:

药理学药理学是指药理学的学科.
神经科学是一个神经科学.
皮肤病学皮肤病学

背景情况:

或是一种常见的感觉,可以成为慢性疾病,导致的循环和感染风险增加.
大麻素已经显示出减少的潜力,但它们的治疗用途通常受到剂量依赖的镇静作用的限制.

研究的目的:

评估大麻素在治疗小鼠实验诱导的的疗效.
为了确定可否在不对运动活动产生不良影响的情况下实现性类药物治疗.
研究CB2大麻素受体在大麻素抗作用中的作用.

主要方法:

在雄性和雌性C57BL/6J小鼠中实验诱导的,使用化合物48/80.
施用不同剂量的合成大麻素激动剂WIN 55,212-2,较小的植物性大麻素Δ8-四大麻素,和甲β-糖烯.
评估CB2受体阻断 (SR144528) 或基因删除对WIN 55,212-2抗活性的影响.
对一种CB2受体选择性激动剂 (JWH-133) 和一种CB1受体调节剂 (ZCZ011) 的评估.

主要成果:

WIN 55,212-2显著减少了抓伤,这种效应被CB2受体对抗或删除取消,表明CB2的关键作用.
选择性CB2激动剂JWH-133也减少了伤,进一步支持CB2受体的参与.
Δ8 - 四大麻素在剂量没有损害运动活动时表现出抗的作用.
相反,β-caryophyllene加剧了抓伤,作为一种剂.

结论:

准CB2大麻素受体代表了管理的有前途的治疗策略.
Δ8 - - 四大麻素可能提供一种潜在的治疗的选择,因为它的有效性没有显著的运动副作用.
应该进一步调查β-caryophyllene是否有可能诱发发.

关键词:

抗剂是一种抗剂.大麻素受体的受体大麻素受体内分泌大麻素系统内分泌大麻素系统皮 (pruritus) 是一种引起皮的疾病.在WIN 55,212-2中使用.Δ(8) - 四化甘醇.这是一种β-caryophyllene.

更多相关视频

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans

Published on: September 21, 2019

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice

Published on: September 2, 2020

相关概念视频

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...